Funder
National Institute on Aging
Publisher
Springer Science and Business Media LLC
Subject
Health Policy,Economics, Econometrics and Finance (miscellaneous)
Reference65 articles.
1. Goldman, D., Jena, A., Philipson, T., Sun, E.: Drug licenses: a new model for pharmaceutical pricing. Health Aff. 27(1), 122–129 (2008)
2. Carlson, J.J., Chen, S., Garrison, L.P., Jr.: Performance-based risk-sharing arrangements: an updated international review. Pharmacoeconomics 35(10), 1063–1072 (2017)
3. Drummond, M.: When do performance-based risk-sharing arrangements make sense? Eur. J. Health Econ. HEPAC Health Econ. Prevent. Care 16(6), 569–571 (2015)
4. Goldman D, Van Nuys K, Cheng W-H, Hlávka JP, Pani L, Chassang S, et al. (2018) A New Model for Pricing Drugs of Uncertain Efficacy. NEJM Catalyst. https://catalyst.nejm.org/doi/full/10.1056/CAT.18.0035. Accessed 18 Aug 2020
5. Jean-Jacques Laffont, D.M.: The theory of incentives: the principal-agent model. Princeton University Press, Princeton (2002)
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献